in reusable containers if done through a contamination-free process. In addition to fighting the buildup of materials and pollution, the nonprofit says reusing containers reduces greenhouse gas ...

For the first time in almost 20 years, Walmart has a new logo. The international retailer describes it as a “a comprehensive brand refresh,” but the online world hasn’t been quite so kind to ...

The Food and Drug Administration on Thursday authorized marketing of 20 nicotine pouches — the first time the products have been greenlit by the agency. Nicotine pouches are tobacco-free sachets ...

Filled Syringes: End-to-End Processing Training Course" conference has been added to ResearchAndMarkets.com's offering. This intensive two-day course has been designed to offer a comprehensive, ...

When the U.S. Food and Drug Administration approves a prescription medication for adults, the drug is also approved for pregnant patients. But information about medication dosing during pregnancy ...

With just days left in the Biden administration, the Food and Drug Administration on Tuesday unveiled its highly anticipated proposal to require manufacturers to display nutrition information on ...

Supernus (SUPN) Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, approved ONAPGO injection, formerly known as SPN-830, as the first and only subcutaneous apomorphine ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals. The drug, Journavx, or suzetrigine, was approved to treat moderate to severe ...

The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed. Recent ...

Breadcrumbs sold for months throughout the United States contain an undeclared allergen and are being recalled for safety reasons, the Food and Drug Administration announced on its website on Jan. 28.

Roche (RHHBY) announced that the Food and Drug Administration has approved Susvimo 100 mg/mL for the treatment of diabetic macular edema, a leading cause of vision loss in adults with diabetes.